Tirzepatide is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes mellitus treatment The most common side effects are gastrointestinal, including nausea, diarrhoea, vomiting, constipation, and abdominal discomfort The medication slows gastric emptying and reduces appetite, which may contribute to digestive symptoms Seek urgent medical attention for severe abdominal pain, persistent vomiting, signs of dehydration, or allergic reactions Report suspected side effects to the MHRA through the Yellow Card scheme Table of Contents Are Hiccups a Side Effect of Mounjaro
Reconstituted: Refrigerate at 28 C (35.646.4 F) and use within about 30 days
Contact your provider promptly if you experience side effects that concern you
The absence of robust evidence stands in contrast to the mounting data supporting GLP-1 monotherapy alone
However, this risk may increase when GLP-1 receptor agonists are combined with insulin or sulfonylureas, and dose adjustments of these medications may be needed
Lodge J: Vitamin E bioavailability in humans
